Novel Immune Strategies to Enhance Beta Cell Replacement Therapies for T1D

This call for proposal seeks innovative and incremental immune modulation and engineering approaches aiming to effectively subvert and/or modulate undesired immune reactivity against implanted cells products towards more tolerogenic responses in vivo. Collaborations including complementary expertise i.e. bioengineers, immunologists, cell biologists, transplant researchers, are highly encouraged and will be prioritized.

 

Only projects with relevance to T1D will be considered.

 

 

 

Funding: $350,000 per year 

Duration: 2 years

 

 

Research Authortiy due date: 18.10.21

LOI (required) due date: 25.10.21

Full proposal due date: 20.12.21